ATGGX | CEUAX | ATGGX / CEUAX | |
Total Expense Ratio | 1.02 | 0.85 | 120% |
Annual Report Gross Expense Ratio | 1.02 | 0.85 | 120% |
Fund Existence | 8 years | 24 years | - |
Gain YTD | 14.848 | 16.102 | 92% |
Front Load | N/A | 4% | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.72B | 135B | 2% |
Annual Yield % from dividends | 0.62 | 0.70 | 89% |
Returns for 1 year | 9.15 | 8.09 | 113% |
Returns for 3 years | 26.23 | 25.81 | 102% |
Returns for 5 years | 4.83 | 13.88 | 35% |
Returns for 10 years | N/A | 40.79 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SWHFX | 23.68 | 0.33 | +1.41% |
Schwab Health Care | |||
ITCTX | 25.88 | N/A | N/A |
VY® T. Rowe Price Capital Apprec S2 | |||
WQAIX | 12.19 | -0.03 | -0.25% |
Westwood Quality AllCap Institutional | |||
NWHTX | 33.90 | -0.14 | -0.41% |
Nationwide Bailard Tech & Sci R6 | |||
BMSSX | 14.87 | -0.07 | -0.47% |
MFS Blended Research Mid Cap Eq R2 |